Evidence map›Paper›PMID 28711869›Full record

ArticleBiology open2017

Establishment of a retinal hypoxia organ culture model.

S Schnichels, M Blak, J Hurst, T Dorfi, K U Bartz-Schmidt, F Ziemssen, M S Spitzer, M Schultheiss

Open access · goldAbstract read
In one paragraph

Article in Biology open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cyclosporine A Protects Retinal Explants against Hypoxia.International journal of molecular sciences · 2021
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

S SchnichelsCentre of Ophthalmology, University Eye Hospital Tübingen, Elfriede-Aulhorn-Str. 7, D-72076 Tübingen, Germany sven.schnichels@med.uni-tuebingen.de.ORCID http://orcid.org/0000-0002-2385-5517
M BlakCentre of Ophthalmology, University Eye Hospital Tübingen, Elfriede-Aulhorn-Str. 7, D-72076 Tübingen, Germany.
J HurstCentre of Ophthalmology, University Eye Hospital Tübingen, Elfriede-Aulhorn-Str. 7, D-72076 Tübingen, Germany.
T DorfiCentre of Ophthalmology, University Eye Hospital Tübingen, Elfriede-Aulhorn-Str. 7, D-72076 Tübingen, Germany.
K U Bartz-SchmidtCentre of Ophthalmology, University Eye Hospital Tübingen, Elfriede-Aulhorn-Str. 7, D-72076 Tübingen, Germany.
F ZiemssenCentre of Ophthalmology, University Eye Hospital Tübingen, Elfriede-Aulhorn-Str. 7, D-72076 Tübingen, Germany.
M S SpitzerCentre of Ophthalmology, University Eye Hospital Tübingen, Elfriede-Aulhorn-Str. 7, D-72076 Tübingen, Germany.
M SchultheissCentre of Ophthalmology, University Eye Hospital Tübingen, Elfriede-Aulhorn-Str. 7, D-72076 Tübingen, Germany.
STZ eyetrial · DEUniversität Hamburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypoxia plays an important role in several retinal diseases, especially in central retinal artery occlusion (CRAO). Although CRAO has been known for over a hundred years, no cure or sufficient treatment is available. Potential therapies are being evaluated in several

Indexed as

Glutamate excitotoxicityHypoxiaOrgan cultureRetinaRGCs

Identifiers

PMID28711869
PMCPMC5550914
OpenAlexW2735433555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.